Clinical trial
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
NCT04674969 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 29, 2021
- Completion date
- January 31, 2028
- Enrollment
- 5,000 (estimated)
- Sites
- 83
Conditions
As the registry lists them; a condition with its own page is linked.